Othus M, Thomas I, Wang X, Ariti C, et al. Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Leuk Lymphoma 2022 Oct 13:1-3. doi: 10.1080/10428194.2022.2131416.
PMID: 36226777